FDA Approved: XELJANZ — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved XELJANZ (tofacitinib) from Pfizer under its original application for rheumatoid arthritis, marking the initial approval of the drug. This introduce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• XELJANZ (tofacitinib)

Snippet

ORIG AP for XELJANZ (TOFACITINIB)